Samsung in Talks to Buy Alzheimer's Drug Maker for $42 Billion: Report
Biogen shares surged following a report that Samsung is in talks to acquire the US biotech company for more than $40 billion (roughly Rs. 2,98,170 crore).
from NDTV Gadgets - Latest https://ift.tt/3Jtfszt
from NDTV Gadgets - Latest https://ift.tt/3Jtfszt
Comments
Post a Comment